Search results

Order by most recent / most popular / relevance

Results: 1-10 of 92

Supreme Court declines to hear Eli Lilly’s “promise of the patent” appeal

Bereskin & Parr LLP
-
Canada
-
May 16 2013

The Supreme Court of Canada denied leave to appeal today from the Federal Court of Appeal ("FCA") decision in Eli Lilly Canada Inc v Novopharm Ltd

Two recent US court decisions deal with the boundaries of patent law in the area of food technologies and computer systems

Bereskin & Parr LLP
-
Canada
-
May 21 2013

The US Federal Circuit Court of Appeals and US Supreme Court have both issued important decisions this week on the scope of US patent law. Ten (10

Is e-commerce changing the definition of trademark “use” in Canada?

Bereskin & Parr LLP
-
Canada
-
April 17 2013

Several recent decisions of the Canadian courts and the Trade-marks Opposition Board (the "Board") analyze the impact of e-commerce on claims of

Supreme Court of Canada denies leave to appeal in PM(NOC) judicial comity case

Bereskin & Parr LLP
-
Canada
-
May 9 2013

The Supreme Court of Canada denied leave to appeal today from the Federal Court of Appeal ("FCA") decision in Allergan Inc. et al ats. Apotex Inc

Retailers’ challenge of the OQLF’s interpretation of the Charter of the French Language

Bereskin & Parr LLP
-
Canada
-
April 30 2013

On October 9, 2012, six retailers, BEST BUY, Costco, GAP, OLD NAVY, GUESS? And WAL-MART, filed a motion in the Superior Court of Quebec seeking a

Enantiomers not eligible for data protection in Canada

Bereskin & Parr LLP
-
Canada
-
February 6 2013

In Canada, innovative drugs are eligible for eight years of data exclusivity under section C.08.004.1 of the Food and Drug Regulations (the

Browse wrap agreements catch notice of courts

Bereskin & Parr LLP
-
Canada
-
July 20 2012

In September 2011, the British Columbia Supreme Court delivered its decision in Century 21 Canada Limited Partnership v. Rogers Communications Inc. doing business as Zoocasa Inc., 2011 BCSC 1196 (Zoocasa

Billion dollar drug litigation opens a front in Canada

Bereskin & Parr LLP
-
Canada
-
June 6 2012

Amgen recently started litigation against Teva over the biologic drug filgrastim (Court File No. T-989-12

The Louboutin decision a step in the right direction for colour marks

Bereskin & Parr LLP
-
Canada, USA
-
October 2 2012

The Second Circuit of Appeal of the United States recently released a decision of importance to brand owners and of particular significance to the fashion industry

Copyright infringement of open source software in Canada

Bereskin & Parr LLP
-
Canada, USA
-
November 4 2008

Open source software (“OSS”) may be used by the public free of charge, however, its use is not free of risk

next >

Search results

Supreme Court declines to hear Eli Lilly’s “promise of the patent” appeal

Two recent US court decisions deal with the boundaries of patent law in the area of food technologies and computer systems

Is e-commerce changing the definition of trademark “use” in Canada?

Supreme Court of Canada denies leave to appeal in PM(NOC) judicial comity case

Retailers’ challenge of the OQLF’s interpretation of the Charter of the French Language

Enantiomers not eligible for data protection in Canada

Browse wrap agreements catch notice of courts

Billion dollar drug litigation opens a front in Canada

The Louboutin decision a step in the right direction for colour marks

Copyright infringement of open source software in Canada

Current Search

Suggested Facets

Author

Jurisdiction

Workarea